Welcome to Francis Academic Press

Frontiers in Medical Science Research, 2022, 4(8); doi: 10.25236/FMSR.2022.040804.

Study on Chitosan Nanoparticles in Liver Cancer


Zhi Zhang1, Zebin Zhang2, Xinxin Wang3, Yulong Li1

Corresponding Author:
Yulong Li

1Institute of Problem Solving, Shaanxi University of Chinese Medicine, Xianyang, China

2Shaanxi University of Chinese Medicine, Xianyang, China

3Northwest University, Xi'an, China 


Liver cancer is one of the most common clinical malignant tumors, but the existing conventional chemotherapy drugs have low bioavailability, poor targeting, while killing cancer cells but also hurt the normal cells of the body, will seriously damage the body's immune system. Nanoparticles are used as drugs, protein, vaccines, nucleic acid fragments and other ideal carriers, widely used in biomedical research and clinical diagnosis and treatment, especially in the treatment of tumors, showing great application prospects. Polysaccharides are the polymer of monosaccharides. As natural biological materials, they are not only highly stable, hydrophilic, safe and non-toxic, but also easy to degrade in vivo. They are the most ideal material for the matrix carrier of nano-drug carrying system. In addition, because chitosan has good biocompatibility and no immunogenic properties on this basis, this paper studies the connection, influence and significance between chitosan nanoparticles and liver cancer based on the improvement of chitosan nanoparticles and the direction of targeted therapy.


Liver cancer; chitosan; nanoparticles; targeted therapy; bioavailability; drugs

Cite This Paper

Zhi Zhang, Zebin Zhang, Xinxin Wang, Yulong Li. Study on Chitosan Nanoparticles in Liver Cancer. Frontiers in Medical Science Research (2022) Vol. 4, Issue 8: 15-18. https://doi.org/10.25236/FMSR.2022.040804.


[1] Li G Y, Zhong M, Zhou Z D, et al. Novel carboxymethyl chitosan microspheres for controlled delivery of chel- erythrine [J]. Journal of Macromolecular Science Part A-Pure Applied Chemistry, 2011, 48(11): 904-911. 

[2] Monier M. Adsorption of Hg2 +, Cu2 + and Zn2 + ions from aqueous solution using formaldehyde cross-linked modi- fied chitosan-thioglyceraldehyde Schiff’s base [J]. Int J Biol Macromol, 2012, 50(3): 773-781.

[3] ElSerag H B,Mason A C. Risk factors for the rising rates of primary liver cancer in the United States. [J]. Archives of internal medicine, 2000, 160(21). 

[4] Niu Jianjun. Association studies of environmental factors, long non-coding RNA and primary hepatocellular carcinoma in men [D]. Xiamen University, 2019. DOI: 10. 27424/d. cnki. gxmdu. 2019. 000553. 

[5] Zhu Guowang. Biological gene therapy for liver cancer is worth exploring [N]. China Medical News, 2010-06-29(B03). DOI:10. 38249/n. cnki. nyiya. 2010. 002383.

[6] Elisa Franco Ribeiro,Taí,s Té,o de Barros-Alexandrino, Odilio Benedito Garrido Assis, Amé,rico Cruz Junior, Amparo Quiles, Isabel Hernando, Vâ,nia Regina Nicoletti. Chitosan and crosslinked chitosan nanoparticles: Synthesis, characterization and their role as Pickering emulsifiers [J]. Carbohydrate Polymers, 2020, 250. 

[7] Zhang Wei. Demethypiegrin low molecular weight chitosan nanoparticle study [D]. Suzhou University, 2008. 

[8] WJ Lin, MH Chen. Synthesis of multifunctional chitosan with galactose as a targeting ligand for glycoprotein receptor [J]. Carbohydr Polym, 2007, 67 (4): 474-480. 

[9] Illum L ,  Farraj N F ,  Davis S S . Chitosan as a Novel Nasal Delivery System for Peptide Drugs[J]. Pharmaceutical Research (New York), 1994, 11(8):1186-1189. 

[10] Bodnar M, Hartmann J F, Borbely J. Preparation and characterization of chitosan -based nanoparticles [J]. Biomacromolecules, 2005, 6 (5): 2521-2527. 

[11] Song Peng. Preparation of novel amphipathic chitosan derivatives and their application in drug carriers [D]. University of Ji'nan, 2012.

[12] Liu Fang. Preparation of folate-targeted TFPI-2 and cisplatin magnetic nanocomplexes and targeted treatment of nasopharyngeal carcinoma [D]. Southern Medical University, 2015. 

[13] Ma Baohua. Preliminary study of chitosan-modified TFu solid lipid nanoparticles [D]. Shandong University, 2009. 

[14] Hulikere Jagdish Shwetha, Shivaprasad Shilpa, Mousumi Beto Mukherjee, Rudrappa Ambedkar, Ashok M. Raichur, Rangaswamy Lakshminarayana. Fabrication of chitosan nanoparticles with phosphatidylcholine for improved sustain release, basolateral secretion, and transport of lutein in Caco-2 cells [J]. International Journal of Biological Macromolecules,2020,163. 

[15] Plabita Gogoi, Anindita Dutta, Anand Ramteke, Tarun Kumar Maji. Preparation, characterization and cytotoxic applications of curcumin‐(±) α‐lipoic acid coloaded phosphorylated chitosan nanoparticles in MDA MB 231 breast cancer cell line [J]. Polymers for Advanced Technologies, 2020, 31 (11). 

[16] Ling Yan, Shengjie Gao, Shanshan Shui, Shuai Liu, Hao Qu, Changhong Liu, Lei Zheng. Small interfering RNA-loaded chitosan hydrochloride/carboxymethyl chitosan nanoparticles for ultrasound-triggered release to hamper colorectal cancer growth in vitro [J]. International Journal of Biological Macromolecules, 2020, 162.